Hep C Calculator launched at the World Hepatitis Summit in São Paulo, Brazil
Hep C Calculator launched at the World Hepatitis Summit in São Paulo, Brazil Dr. Chhatwal officially launched the Hep C Calculator (http://www.hepccalculator.org/)-- interactive online tool for global cost-effectiveness of hepatitis C treatment -- at the World Hepatitis Summit in São Paulo.
Los Angeles Times: Even in best-case scenario, opioid overdose deaths will keep rising until 2022
A new projection of opioid overdose death rates suggests that even if there is steady progress in reducing prescription narcotic abuse across the country, the number of fatal overdoses — which reached 47,600 in 2017 — will rise sharply in
US News: Opioid death toll could top 700,000 over a decade
TACKLING PRESCRIPTION drug abuse will hardly make a dent in America's ongoing opioid crisis in the coming years, a new study suggests. "People who start using prescription opioids, at some point, may transition to the next stage, (and) as the supply-side
How the anal cancer epidemic in gay and bi HIV-positive men can be prevented
Almost 620,000 gay and bisexual men in the United States were living with HIV in 2014, and 100,000 of these men were not even aware of their infection. These men are 100 times more likely to have anal cancer than
Economic Times: How beneficial are generic hepatitis C drugs available in India?
New York: Use of the generic versions of directly-acting antiviral (DAA) drugs that are available in India to treat hepatitis C virus (HCV) infection can increase lifespan while reducing lifetime health care costs, says a study. Compared with no DAA
Boston’s NPR Interview: As Cancer Drugs’ Prices Skyrocket, Experts Worry About Burden On Patients, Health Systems
WBUR examined fast-moving changes in cancer research and treatment in a series we're calling, "This Moment In Cancer." Leaders in cancer research say the field has reached a pivotal moment, including the discovery of new treatments. But, these new treatments come
From The War On Cancer To The Moonshot: ‘What’s Different Now Is Everything’
This story is part of our "This Moment In Cancer" series. Nearly a half-century separates the Obama administration's Cancer Moonshot from President Richard Nixon’s War on Cancer. But Greg Simon, the moonshot's inaugural director, says the two programs are really one
NPR Marketplace Interview: Cutting prison hepatitis C rates: costly, but worth it?
Dr. Jag Chhatwal, assistant professor of radiology at Harvard Medical School, has studied the economics of treating hepatitis C in prisons and said that while the drugs are expensive, liver transplants and treatment for patients with hepatitis C in its
STAT: Prisons can lock up savings by treating inmates with hepatitis C
The high cost of hepatitis C drugs may be straining budgets nationwide, but the country can save money if prison inmates are screened and treated for the disease, according to a new study. “The problem is that not enough prisoners
NPR Interview: Treating Prisoners With Hepatitis C May Be Worth The Hefty Price
Doctors, patients and insurers have been struggling with how to determine who should be treated for hepatitis C now that effective but wildly expensive drugs can all but cure the disease. Treating prison inmates is a good investment that would